Ryan MP, Winsett FT, Armenta AM, Goodwin BP, Wagner RF. Lymphovascular Invasion in Cutaneous Squamous Cell Carcinoma.
Dermatol Surg 2024;
50:699-704. [PMID:
38603804 DOI:
10.1097/dss.0000000000004187]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/13/2024]
Abstract
BACKGROUND
Although there is a large body of literature regarding risk stratification and outcomes for perineural invasion (PNI) in cutaneous squamous cell carcinoma (cSCC), there is a relative paucity of studies exploring the role of lymphovascular invasion (LVI) in cSCC and a lack of clear evidence-based guidelines for how to manage patients with these tumors.
OBJECTIVE
This article is intended to review the available literature regarding LVI in cSCC and formulate evidence-based recommendations for clinical management.
METHODS AND MATERIALS
A literature review was conducted using PubMed to find relevant articles relating to outcomes and management of primary cSCC with LVI.
RESULTS
The available literature suggests that LVI is a major risk factor for poor outcomes and increased morbidity and mortality in cSCC.
CONCLUSION
Lymphovascular invasion is a very high-risk feature that should place these tumors in the highest-risk category, and management of these tumors should be similar to that of squamous cell carcinoma with PNI.
Collapse